(7 days)
No
The summary describes standard image processing techniques for calculating perfusion parameters from CT data and does not mention AI, ML, or related concepts.
No
The device is a noninvasive post-processing software designed to evaluate perfusion and provide data for diagnosis and therapy monitoring, not to directly treat or alter a patient's condition.
Yes
The software evaluates perfusion to differentiate blood flow between normal and diseased tissue, which is a diagnostic function.
Yes
The device is described as a "software package" and "noninvasive post-processing software" that runs on a PC console of a host CT device. It processes existing image data and does not include any hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device function: The Body Perfusion System software processes imaging data (dynamic CT scans) acquired from the patient's body. It does not analyze biological specimens taken from the body.
- Intended Use: The intended use is to evaluate perfusion of organs and tumors based on imaging data, not to analyze biological samples.
Therefore, this device falls under the category of medical image processing software rather than an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Body Perfusion System software package is a noninvasive post-processing package that has been designed to evaluate perfusion of organs and tumors. The software can calculate blood flow, blood volume and permeability from sets of images reconstructed from dynamic CT data acquired after the injection of contrast media. The software also allows the separate calculation of the arterial and portal venous component of hepatic perfusion. It supports evaluation of regions of interest and the visual inspection of time density curves.
When used by a qualified physician a potential application is to differentiate blood flow between normal and diseased tissue. Determination of the change of perfusion parameters during the course of treatment may be helpful in therapy monitoring.
It should be used by a trained and qualified physician.
Product codes
JAK
Device Description
The CSBP-001A is a noninvasive post-processing software that runs on a PC based console of the host CT device. It has been designed to assess dynamic (time lapsed collections) CT volume scans and provide data related to the volume sets.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT
Anatomical Site
Body, Organs, tumors, hepatic
Indicated Patient Age Range
Not Found
Intended User / Care Setting
qualified physician, trained and qualified physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
5 2009
Toshiba America Medical Systems, Inc. Premarket Notification Body Organ Perfusion System, CSBP-001 A
| Section 5. 510(k) Summary | MAR |
|---|---|
| Date: | February 18, 2009 |
| Manufacturer: | Toshiba Medical Systems Corporation |
| 1385 Shimoishigami, Otawara-shi, | |
| Tochigi-ken, 324-8550, Japan | |
| Initial Importer/Distributor: | |
| Address: | |
| Contact: | Toshiba America Medical Systems, Inc. |
| P.O. Box 2068, 2441 Michelle Drive, | |
| Tustin, CA 92781-2068 | |
| Paul Biggins, Director Regulatory Affairs | |
| (714)730-5000 | |
| Establishment Registration | |
| Number: | 2020563 |
| Device Proprietary Name: | CSBP-001A; Body Perfusion System |
| Common Name: | Scanner, Computed Tomography, X-Ray |
| Classification: | 90-JAK |
| Regulatory Class: | II (per 21 CFR 892.1750) |
| Performance Standard: | None |
| Predicate Device(s): | General Electric CT Perfusion 4 (K052839 |
| Siemens syngo Perfusion (K073373) | |
| Reason For Submission | New software device |
Description of this Device:
The CSBP-001A is a noninvasive post-processing software that runs on a PC based console of the host CT device. It has been designed to assess dynamic (time lapsed collections) CT volume scans and provide data related to the volume sets.
Summary of Intended Uses:
The Body Perfusion System software package is a noninvasive post-processing package that has been designed to evaluate perfusion of organs and tumors. The software can calculate blood flow, blood volume and permeability from sets of images reconstructed from dynamic CT data acquired after the injection of contrast media. The software also allows the separate calculation of the arterial and portal venous component of hepatic
1
Toshiba America Medical Systems, Inc. Premarket Notification Body Organ Perfusion System, CSBP-001A
perfusion. It supports evaluation of regions of interest and the visual inspection of time density curves.
When used by a qualified physician a potential application is to differentiate blood flow between normal and diseased tissue. Determination of the change of perfusion parameters during the course of treatment may be helpful in therapy monitoring.
It should be used by a trained and qualified physician.
Safety and Effectiveness Concerns:
This device is designed and manufactured under the Quality System Regulations as outlined in 21 CFR § 820. Additionally, risk management is employed through hazard analysis which identifies potential hazards. These hazards are mitigated through labeling and software development.
Substantial Equivalence:
This device is substantially equivalent to the predicate devices which are commercially available at this time.
| GE CT Perfusion 4
Siemens syngo Volume
| Perfusion CT Body | K052839 | March 10, 2006 |
|---|---|---|
| K073373 | December 18, 2007 |
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol of three horizontal lines that curve downwards, resembling a human figure.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
5 2009 MAR
Toshiba America Medical Systems, Inc. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
Re: K090504
Trade/Device Name: Body Perfusion System, CSBP-001A Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: February 25, 2009
Received: February 26, 2009
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801: good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding os substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | (240) 276-0115 |
|---|---|---|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | (240) 276-0115 |
| 21 CFR 892.xxx | (Radiology) | (240) 276-0120 |
| Other | (240) 276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufactures. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry.suppot/index.html.
Sincerely yours,
Janine M. Morris
anine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
4
Indications for Use
090500 510(k) Number (if known):
Device Name: Body Perfusion System, CSBP-001A
Indications for Use:
The Body Perfusion System software package is a noninvasive post-processing package that has been designed to evaluate perfusion of organs and tumors. The software can calculate blood flow, blood volume and permeability from sets of images reconstructed from dynamic CT data acquired after the injection of contrast media. The software also allows the separate calculation of the arterial and portal venous component of hepatic perfusion. It supports evaluation of regions of interest and the visual inspection of time density curves.
When used by a qualified physician a potential application is to differentiate blood flow between normal and diseased tissue. Determination of the change of perfusion parameters during the course of treatment may be helpful in therapy monitoring.
It should be used by a trained and qualified physician.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| (Division Sign-Off) | |
| Division of Reproductive, Abdominal and | |
| Radiological Devices | |
| 510(k) Number | K090504 |
| Page 1 of 1 |